Concepedia
Statistics
Publications
32
Citations
1.8K
H-Index
25
Active since
1975
Affiliations
Research Triangle Park Foundation(Current)
Burroughs Wellcome Fund
University of North Carolina at Chapel Hill
GlaxoSmithKline (United States)
I K Dev is an author at Research Triangle Park Foundation specializing in life sciences, biochemistry, and enzymology.
Publications per year
1975–2008
The effect of anti-VEGF therapy on immature myeloid cell and dendritic cells in cancer patients
Takuya Osada, Gabriel T. Chong, Robert L. Tansik et al. · Cancer Immunology Immunotherapy · 2008 · 310 citations · Full text
Medicine, Immunology, Oncology +17
Inhibition of prolipoprotein signal peptidase by globomycin.
I K Dev, Richard J. Harvey, Paul H. Ray · Journal of Biological Chemistry · 1985 · 122 citations · Full text
Life Sciences, Biochemistry, Molecular Biology +6
Biochemical and cellular pharmacology of 1843U89, a novel benzoquinazoline inhibitor of thymidylate synthase.
David S. Duch, Sheila D. Banks, I K Dev et al. · PubMed · 1993 · 114 citations
Life Sciences, Biochemistry, Pharmacology +9
Cloning, sequencing, and enhanced expression of the dihydropteroate synthase gene of Escherichia coli MC4100
W S Dallas, Jeanette Gowen, Paul H. Ray et al. · Journal of Bacteriology · 1992 · 111 citations · Full text
Life Sciences, Biochemistry, Molecular Biology +17
Rapid assay and purification of a unique signal peptidase that processes the prolipoprotein from Escherichia coli B.
I K Dev, Paul H. Ray · Journal of Biological Chemistry · 1984 · 87 citations · Full text
Life Sciences, Biochemistry, Molecular Biology +12
1–5 of 32